Skip to main content

Advertisement

Log in

No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Endothelial nitric oxide synthase (eNOS)–derived nitric oxide (NO) is involved in numerous physiologic and pathophysiologic process including tumor angiogenesis and apoptosis. Accordingly, the present study analyzed polymorphisms of eNOS gene and their impact on the prognosis for patients with colorectal cancer. Four hundred and forty-four consecutive patients with surgically resected colorectal adenocarcinoma were enrolled in the present study. The genomic DNA was extracted from fresh colorectal tissue and 2 polymorphisms of eNOS gene (eNOS T786C and eNOS G894T) determined using a real-time PCR genotyping assay. The 2 eNOS gene polymorphisms were successfully amplified, and the frequencies of each genotype are as follows [T786C: TT (82.2%), TC (16.9%), CC (0.9%); G894T: GG (82.0%), GT (17.3%), TT (0.7%)]. Multivariate survival analysis including stage, age, site of disease, and CEA level showed that these polymorphisms were not associated with survival. For the clinicopathologic parameters, CEA level and TNM stage were significant prognostic factors in a Cox model for survival. The eNOS gene polymorphisms investigated in this study were not found to be an independent prognostic marker for Korean patients with surgically resected colorectal cancer. However, further studies are warranted to clarify the role of the eNOS gene polymorphisms as a prognostic biomarker for colorectal patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6(7):521–34.

    Article  PubMed  CAS  Google Scholar 

  2. Choi BM, et al. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol. 2002;35(1):116–26.

    Article  PubMed  CAS  Google Scholar 

  3. Hu DE, et al. Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Res. 2004;64(1):152–61.

    Article  PubMed  CAS  Google Scholar 

  4. Jadeski LC, Chakraborty C, Lala PK. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer. 2003;106(4):496–504.

    Article  PubMed  CAS  Google Scholar 

  5. Xu W, et al. Mapping of the genes encoding human inducible and endothelial nitric oxide synthase [NOS2 and NOS3] to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics. 1994;21(2):419–22.

    Article  PubMed  CAS  Google Scholar 

  6. Nakayama M, et al. T-786 → C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99(22):2864–70.

    PubMed  CAS  Google Scholar 

  7. Yoshimura M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998;103(1):65–9.

    Article  PubMed  CAS  Google Scholar 

  8. Veldman BA, et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002;20(10):2023–7.

    Article  PubMed  CAS  Google Scholar 

  9. Xu W, et al. The role of nitric oxide in cancer. Cell Res. 2002;12(5-6):311–20.

    Article  PubMed  Google Scholar 

  10. Hefler LA, et al. Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol. 2002;86(2):134–7.

    Article  PubMed  CAS  Google Scholar 

  11. Medeiros R, et al. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev. 2002;11(4):343–50.

    Article  PubMed  CAS  Google Scholar 

  12. Medeiros RM, et al. Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin Cancer Res. 2002;8(11):3433–7.

    PubMed  CAS  Google Scholar 

  13. Hamilton SRAL. WHO Classification. Lyon, France: IARC Press; 2000.

    Google Scholar 

  14. Greene FLPD, Fleming ID. The AJCC Cancer Staging Manual. 6th edn ed. New York: Springer; 2002.

    Google Scholar 

  15. Fukumura D, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001;98(5):2604–9.

    Article  PubMed  CAS  Google Scholar 

  16. Hagendoorn J, et al. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res. 2004;95(2):204–9.

    Article  PubMed  CAS  Google Scholar 

  17. Yeh CC, et al. An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer. 2009;124(7):1565–71.

    Article  PubMed  CAS  Google Scholar 

  18. Cheon KT, et al. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung. 2000;178(6):351–60.

    Article  PubMed  CAS  Google Scholar 

  19. Lee KM, et al. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis. 2009;30(4):621–5.

    Article  PubMed  CAS  Google Scholar 

  20. Hefler LA, et al. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat. 2006;98(2):151–5.

    Article  PubMed  CAS  Google Scholar 

  21. Ghilardi G, et al. Vascular invasion in human breast cancer is correlated to T → 786C polymorphism of NOS3 gene. Nitric Oxide. 2003;9(2):118–22.

    Article  PubMed  CAS  Google Scholar 

  22. Riener EK, et al. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol. 2004;93(3):686–90.

    Article  PubMed  CAS  Google Scholar 

  23. Choi JY, et al. Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res Treat. 2006;100(2):213–8.

    Article  PubMed  CAS  Google Scholar 

  24. Funke S, et al. Genetic Polymorphisms in Genes Related to Oxidative Stress [GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS] and Survival of Rectal Cancer Patients after Radiotherapy. J Cancer Epidemiol. 2009;302047:1–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong Gwang Kim.

Additional information

Jong Gwang Kim and Gyu Seog Choi contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, Y.J., Lee, S.J., Kim, J.G. et al. No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer. Med Oncol 28, 1075–1079 (2011). https://doi.org/10.1007/s12032-010-9647-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9647-4

Keywords

Navigation